Enterprise Innovation Institute

LivaNova receives 510(k) clearance for ECMO for LifeSPARC

Posted on: November 28, 2022

LivaNova, a medical technology company, has received 510(k) clearance for extracorporeal membrane oxygenation (ECMO) from the FDA for LifeSPARC, the company’s next-generation Advanced Circulatory Support (ACS) pump and controller pump system.

Read full post: Read More